Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity), along with tirzepatide (Mounjaro, Zepbound)a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonistare effective medications for type 2 diabetes and weight management
Binding of GLP-1 or GLP-1RAs to these receptors can activate the cAMP/PKA signaling pathway, affecting key transcription factors like NF-B
Viral peptides with structural homology to islet autoantigens (e.g., GAD65) are processed and presented by HLA class II molecules on antigen-presenting cells [6, 7, 71,72,73]
Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System
While GLP-1 agonists primarily work through appetite suppression (the input side of the energy equation), glucagon activation works on the output side, increasing how many calories the body burns at rest
It doesnt just reduce fat
